Article
Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status.
BMC cancer - 6 Feb 2021
He Xuejun, You Jijun, Ding Haibing, Zhang Zhisheng, Cui Lin, Shen Xiaomei, Bian Xiaoxia, Liu Yanqing, Chen Jue
Abstract excerpt
BACKGROUND: Vascular mimicry (VM) was associated with the prognosis of cancers. The aim of the study was to explore the association between VM and anticancer therapy response in patients with lung adenocarcinoma. METHODS: This was a single-center retrospective study of patients with lung adenocarcinoma between March 1st, 2013, to April 1st, 2019, at the Second People's Hospital of Taizhou City. All included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.